Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Oxford University spin-out developing next-generation CSP and solar thermal storage technologies to decarbonise industrial heat processes
Software for mobile robots
PQShield is a post-quantum cryptography company that develops cryptographic algorithms and protocols to secure technology infrastructures.
Amber Therapeutics develops the next-generation of bioelectrical therapies.
Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.
Allos is a solution to prognose, monitor, and treat autoimmune conditions.
Beacon Therapeutics is a biotechnology company that develops treatments to preserve and restore vision for rare and prevalent eye diseases.
Scripta Therapeutics operates as a bio-tech company.
Valink Therapeutics is a health care drug discovery for next-generation cancer treatments.
Wild Bioscience is a crop improvement company that provides carbon mitigation, yield enhancement, and farm productivity solutions.
Kneu Health transforms smart phones into clinical-grade monitors to keep a tab on neurological conditions like Parkinson’s and dementia.
Oath Surgical operates with distinction, offering our patients, associates, and partners unmatched value and experiences.
PepGen is empowering nucleic acid therapeutics to go the distance.
NavLive creates instant 2D and 3D models, along with accurate site surveys using user-friendly Scan-to-BIM functionality.
Mode Labs provide robust, continuous, and remote real-time chemical sensors.
Diffblue is a developer of automated testing software that enhances Java development by automatically generating unit tests.
Seloxium is innovative research that makes it possible to extract necessary metals in an environmentally friendly manner.
Alloyed develops, licenses, and manufactures proprietary alloys, alloy powders and alloy components.
Mixergy offer a cost-effective solution to save energy and facilitate more renewable power generation.
Neu Health enables clinicians, caregivers, and patients to tackle this growing challenge with cutting-edge digital technologies.
Oxford Flow is able to save money without sacrificing performance.
Perspectum provides imaging solutions to help doctors in clinical decision-making as well as support patient engagement.
Caristo Diagnostics is a biotech company that provides diagnostic platforms for heart diseases, stroke, and diabetes.
natcap is a nature intelligence company that provides report and act on impacts and dependencies on nature.
Oxford Science Enterprises has invested in 138 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Oxford Science Enterprises's top investment sectors include Health Care, Biotechnology, Therapeutics, Software, Medical. The firm invests across 49 different industry categories.
Among tracked funding rounds, Pepgen received $115.0M in a Post-IPO Equity round. Oxford Science Enterprises's total known invested capital is $3.3B.
Oxford Science Enterprises's average investment size is $23.9M across its portfolio of 138 companies.
Recent Oxford Science Enterprises portfolio additions include Odqa Renewable Energy Technologies, Stateful Robotics, PQShield, Amber Therapeutics, Theolytics. These companies were founded in 2020 or later.